These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 4671627

  • 21. Effects of a single massive intravenous dose of hydrocortisone in rheumatoid arthritis.
    Haataja M, Kalliomaki JL.
    Curr Ther Res Clin Exp; 1975 Jan; 17(1):80-7. PubMed ID: 806432
    [No Abstract] [Full Text] [Related]

  • 22. [Relationships between rheumatoid arthritis and ankylosing spondylitis].
    Josenhans G.
    Z Rheumaforsch; 1968 Oct; 27(9):319-25. PubMed ID: 5721687
    [No Abstract] [Full Text] [Related]

  • 23. [The clinical significance of CRP (C-reactive protein) monitoring].
    Fehr J.
    Ther Umsch; 1988 Feb; 45(2):85-92. PubMed ID: 3358246
    [No Abstract] [Full Text] [Related]

  • 24. [The determination of collagen antibodies and the so-called "collagen-like protein" (CLP) in serum in ankylosing spondylitis].
    Langness U, Kriegel W, Jahn P.
    Verh Dtsch Ges Rheumatol; 1969 Feb; 1():211-5. PubMed ID: 5403953
    [No Abstract] [Full Text] [Related]

  • 25. [Results of clinical management of patients with very active rheumatoid arthritis. Comparative demonstration of therapy with non-steroid antiphlogistics, gold salts and the immunosuppressive agents proresid and endoxan].
    Wawrzyńska-Pagowska J, Graff-Wróblewska T, Juszczyk T, Michalski J, Pakula A, Piotrowska D, Scislowska M.
    Z Rheumaforsch; 1973 Feb; 32(1):32-9. PubMed ID: 4693416
    [No Abstract] [Full Text] [Related]

  • 26. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers.
    Keyszer G, Lambiri I, Nagel R, Keysser C, Keysser M, Gromnica-Ihle E, Franz J, Burmester GR, Jung K.
    J Rheumatol; 1999 Feb; 26(2):251-8. PubMed ID: 9972954
    [Abstract] [Full Text] [Related]

  • 27. [Simple saccharides in the plasmatic and erythrocytic mucoids in diseases of the locomotor system and hematologic diseases].
    Stĕpán J.
    Vnitr Lek; 1971 May; 17(5):463-8. PubMed ID: 5162708
    [No Abstract] [Full Text] [Related]

  • 28. [Protein separation using polyacrylamide gel electrophoresis and demonstration of differences of the gamma-globulins in various diseases, rheumatism].
    Geyer G, Ebermann R, Barna J.
    Z Rheumatol; 1974 May; 33(11-12):437-41. PubMed ID: 4141830
    [No Abstract] [Full Text] [Related]

  • 29. [Level of antistreptolysin O (ASO) in various pathological conditions connected with the locomotor system].
    Cam HD.
    Reumatologia; 1975 May; 13(3):201-6. PubMed ID: 1179063
    [No Abstract] [Full Text] [Related]

  • 30. [Laboratory diagnosis of rheumatoid arthritis].
    Ravetta A.
    Arch Sci Med (Torino); 1970 May; 127(10-12):333-42. PubMed ID: 5519849
    [No Abstract] [Full Text] [Related]

  • 31. [Diagnosis of rheumatoid arthritis activity].
    Erov NK, Petrova VI, Shukurov OSh.
    Ter Arkh; 1977 May; 49(12):93-5. PubMed ID: 74862
    [No Abstract] [Full Text] [Related]

  • 32. ON THE MECHANISM OF DIFFERENCES IN SEROMUCOID VALUES OBTAINED FROM SERUM AT VARIOUS TEMPERATURES.
    STEPAN J, KAKAC B, PALUSKA E.
    Med Exp Int J Exp Med; 1963 May; 9():183-90. PubMed ID: 14083339
    [No Abstract] [Full Text] [Related]

  • 33. [Ankylosing spondylitis in Portugal].
    de Pap L.
    Verh Dtsch Ges Rheumatol; 1969 May; 1():81-90. PubMed ID: 5403661
    [No Abstract] [Full Text] [Related]

  • 34. [On the behavior of fucose, sialic acid and mucoproteins in patients with malignant neoplasms before and after roentgen therapy].
    Guerrina G, Traverso G.
    Pathologica; 1970 May; 62(907):75-8. PubMed ID: 5523517
    [No Abstract] [Full Text] [Related]

  • 35. Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis.
    Spoorenberg A, van der Heijde D, de Klerk E, Dougados M, de Vlam K, Mielants H, van der Tempel H, van der Linden S.
    J Rheumatol; 1999 Apr; 26(4):980-4. PubMed ID: 10229432
    [Abstract] [Full Text] [Related]

  • 36. [Gm properties in rheumatoid diseases with special reference to chronic progressive polyarthritis. II. Anti-Gm factors n rheumatoid diseases].
    Neumann W, Barthel E, Tanner E, Seidel K.
    Z Gesamte Inn Med; 1970 Jun 01; 25(11):500-5. PubMed ID: 5523394
    [No Abstract] [Full Text] [Related]

  • 37. The assessment of rheumatoid arthritis. A study based on measurements of the serum acute-phase reactants.
    McConkey B, Crockson RA, Crockson AP.
    Q J Med; 1972 Apr 01; 41(162):115-25. PubMed ID: 4561431
    [No Abstract] [Full Text] [Related]

  • 38. [Evaluation and treatment of hyperuricemia].
    Wolfram G.
    Med Welt; 1973 Dec 14; 24(50):1969-73. PubMed ID: 4776217
    [No Abstract] [Full Text] [Related]

  • 39. Gout and main rheumatic diseases in man.
    Sorghi ML, Quaratino CP, Savini F, Zoppini A, Giacomello A.
    Adv Exp Med Biol; 1991 Dec 14; 309A():227-30. PubMed ID: 1789213
    [No Abstract] [Full Text] [Related]

  • 40. [A new pharmaceutical form of indomethacin in the treatment of chronic arthropathies].
    Colombo B, Amira A, Carrabba M.
    Reumatismo; 1971 Dec 14; 23(6):295-303. PubMed ID: 5164680
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.